Analysis Of Body Fluids Research Articles

Analysis of Aflatoxin Biomarkers in the Hair of Experimental Animals.

Analysis of body fluids and tissues of aflatoxin exposed individuals for the presence of aflatoxins and aflatoxin metabolites has emerged as a reliable indicator of exposure and metabolism of aflatoxins. However, current aflatoxin biomarkers are not appropriate for investigating the long-term effects of aflatoxin exposure. In this explorative study, we investigated the analysis of hair as a complementary or alternative matrix for the assessment of biomarkers of long-term aflatoxin exposure. Three groups of guinea pigs were orally dosed with 5 ugkg−1bw−1, 50 ugkg−1bw−1, and 100 ugkg−1bw−1 of AFB1. Urine and hair samples were collected on days 0, 1, 2, 3, 7, 30, 60, and 90 and analysed for AFB1 and AFM1 using UHPLC-MS/MS. AFB1 and AFM1 were detected in 75% and 13.6%, respectively, of the day 1 to day 7 urine samples. AFB1 was detected in hair samples collected from day 3 up to day 60. This is the first report to confirm the deposition of AFB1 in the hair of experimental animals. These findings indicate that hair analysis has the potential to provide an accurate long-term historical record of aflatoxin exposure with potentially important implications for the field of aflatoxin biomarkers.

Efficient extraction of quaternary ammonium alkaloids based on π-conjugated polymer coated porous silica adsorbent

The analysis of body fluids (blood, urine, serum, etc.) to accurately detect drug contents has garnered considerable attention in pharmacokinetic and other related studies. Due to the complicated composition of body fluids and low concentration of drugs, efficient implementation of solid phase extraction (SPE) technology is a powerful strategy. This study introduces the preparation of novel π-conjugated polymer modified porous silica (SiO2@π-CP) as adsorbent for extraction of quaternary ammonium alkaloids (QAAs). The preparation process of SiO2@π-CP is easy and the cost is low. Due to the existing of large conjugate structure and rich polar groups (hydroxyl and amine) in π-CP, SiO2@π-CP can form efficient interactions with QAAs (jatrorrhizine, berberine, chelerythrine and sanguinarine as the model analytes). In order to get a better understanding about the adsorption mechanism and process, adsorption kinetics, adsorption isotherms, and thermodynamic studies were conducted. SiO2@π-CP was also proven to have outstanding corrosion resistance and reusability. By investigating the main SPE parameters, the SPE method based on SiO2@π-CP was developed. Excellent results were obtained, including satisfied limits of detections (0.5–2.0 ng/mL), limits of quantifications (0.5–20.0 ng/mL), linearities (0.5–4000 ng/mL), RSDs of inter-day (0.9%–3.4%) and intra-day (1.7–5.0%). This research highlights the novel SiO2@π-CP adsorbent possesses the potential for addressing the enrichment of QAAs in real urine samples.

A sample-preparation-free, automated, sample-to-answer system for cell counting in human body fluids.

While many clinical laboratory tests are now highly automated, body fluid cell counting, particularly in low-cellularity samples such as cerebral spinal fluid (CSF), is often performed manually. Here, we report a simple, cost-effective method to obtain white and red blood cell counts from human body fluids such as CSF. The method consists of a compact, automated, and low-cost fluorescence microscope system, coupled to a sample chamber containing all of the necessary reagents in dry form to stain and prepare the sample. Sample focus and scanning are handled automatically, and the acquired multimodal images are automatically analyzed to extract cell counts. Comparison with manual counting on over 200 clinical samples shows excellent agreement. As the system counts a substantially larger image region than a standard manual cell count, we find our sensitivity to extremely low cellularity samples to potentially be higher than the manual gold standard, evidenced by our system recording images of cells in samples whose cell count was registered as "0" by a trained user. Thus, our system holds promise for routine, automated, and sensitive analysis of body fluids whose cellularity extends across a wide dynamic range.

Evaluate the bacterial infections in Indian cirrhotic patients: a prospective study

Background: Bacterial infections (BI) are more prevalent in liver cirrhosis (LC), high among hospitalized patients. The aim of the study was to explore epidemiological pattern of BI in hospitalized patients with LC with identification of the causative agents. Objective of the study was evaluation of therapeutic/empirical approaches for infections.Methods: Inputs from the body fluid analysis and culture reports were recorded. Child Pugh score (CPS) was used to assess the severity of liver disease. Antibiotic treatment strategy was analysed, prescribed antibiotics were checked for contraindications using Lexicomp software.Results: Of 60 enrolled patients, four had mixed infection and 55% were culture positive. There was a male preponderance (83.3%). BI was more frequent in those aged 51-60 years (38.3%) and >60 years (35%). Higher proportion of patients (60%) belonged to class C of CPS followed by class B (31.7%). The most common causative organisms identified were E. coli (28.5%), K. pneumonia (14.2%), Enterococcus spp (11.4 %) and less common were K. oxytoca, Coagulase-negative staphylococci, Staphylococcus aureus, gram-positive cocci, gram-negative cocci, P. aeruginosa, S. hemolyticus, ß-hemolytic streptococcus spp. Majority of subjects had spontaneous bacterial peritonitis (36.7%) followed by urinary tract infection (21%), lower respiratory tract infection (18.3%), Sepsis (13.3%), cellulitis (3.3%) and acute gastroenteritis (1.7%). Cephalosporin's (61.7%), (rifaximin) (51.7%), penicillin and β lactamase inhibitors (36.7%) were the common prescribed antimicrobials.Conclusions: There is a positive association between the risk of BI and severity of liver damage.

A New Methodology for the Assessment of Very Low Concentrations of Cells in Serous Body Fluids Based on the Count of Ultrasound Echoes Backscattered From Cells.

A methodology for the assessment of cell concentration, in the range 5-100 cells/ [Formula: see text], suitable for in vivo analysis of serous body fluids is presented in this work. This methodology is based on the quantitative analysis of ultrasound images obtained from cell suspensions and considers applicability criteria, such as short analysis times, moderate frequency, and absolute concentration estimation, all necessary to deal with the variability of tissues among different patients. Numerical simulations provided the framework to analyze the impact of echo overlapping and the polydispersion of scatterer sizes on the cell concentration estimation. The cell concentration range that can be analyzed as a function of the transducer and emitted waveform used was also discussed. Experiments were conducted to evaluate the performance of the method using 7- [Formula: see text] and 12- [Formula: see text] polystyrene particles in water suspensions in the 5-100 particles/ [Formula: see text] range. A single scanning focused transducer working at a central frequency of 20 MHz was used to obtain ultrasound images. The method proposed to estimate the concentration proved to be robust for different particle sizes and variations of gain acquisition settings. The effect of tissues placed in the ultrasound path between the probe and the sample was also investigated using 3-mm-thick tissue mimics. Under this situation, the algorithm was robust for the concentration analysis of 12 [Formula: see text] particle suspensions, yet significant deviations were obtained for the smallest particles.

A Cost-Effective, Impediometric Na+-Sensor in Fluids

A crucial parameter in the body-fluid analysis is Na <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">+</sup> -ions. Preferably realized as a small wearable, mostly the fabrication method, size, and costs prevented ion-selective devices to enter the big realm of IoT applications. This letter reports a printed, electrochemical sensor system for measuring Na <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">+</sup> -ions in liquids. We designed, simulated, optimized, fabricated, and experimentally evaluated the sensor structures. Employing electrochemical impedance spectroscopy on a printable, dielectric ion-selective membrane, reproducible 2-electrode-measurement results are achieved in a biological-relevant mM-range. The cross-sensitivity toward K <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">+</sup> -ions, dynamic range, and drift are investigated, and a robust measurement scheme is derived. The flexible, low-cost approach can enable new Internet-of-Things and point-of-care applications in biomedicine such as sweat analysis and environmental monitoring.

Automated cell count in body fluids: a review.

Body fluid cell counting provides valuable information for the diagnosis and treatment of a variety of conditions. Chamber cell count and cellularity analysis by optical microscopy are considered the gold-standard method for cell counting. However, this method has a long turnaround time and limited reproducibility, and requires highly-trained personnel. In the recent decades, specific modes have been developed for the analysis of body fluids. These modes, which perform automated cell counting, are incorporated into hemocytometers and urine analyzers. These innovations have been rapidly incorporated into routine laboratory practice. At present, a variety of analyzers are available that enable automated cell counting for body fluids. Nevertheless, these analyzers have some limitations and can only be operated by highly-qualified laboratory professionals. In this review, we provide an overview of the most relevant automated cell counters currently available for body fluids, the interpretation of the parameters measured by these analyzers, their main analytical features, and the role of optical microscopy as automated cell counters gain ground.

Assessing Adherence to Antihypertensive Medication by Means of Dose-Dependent Reference Plasma Concentration Ranges and Ultra-High Performance Liquid Chromatography-Ion Trap Mass Spectrometry Analysis.

Poor adherence to antihypertensive drug therapy is a well-recognized problem and can be assessed by mass spectrometry-based analyses of body fluids. However, contrary statements exist whether drug quantification in blood or qualitative screening in urine is more suitable. The present pilot study aimed to further elucidate the power of blood plasma drug concentrations for adherence monitoring by developing and validating a quantification procedure for nine antihypertensive drugs (amlodipine, bisoprolol, candesartan, canrenone, carvedilol, metoprolol, olmesartan, torasemide, and valsartan) in blood plasma using liquid–liquid extraction and an ultra-high-performance liquid chromatography-ion trap mass spectrometry analysis. The procedure should then be used for an adherence assessment and compared with the results of an established qualitative urine screening. Selectivity, carryover, matrix effect, accuracy, precision, dilution integrity, and stability were successfully validated, except for amlodipine. The applicability was demonstrated by analyzing 19 plasma samples containing 28 antihypertensive drugs and comparing the measured concentrations with calculated dose-dependent reference plasma concentration ranges. The interpretation of plasma concentrations was found to be more sophisticated and time-consuming than that of urine screening results, and adherence could not be assessed in two cases (10%) due to measured plasma concentrations below the lower limit of quantification. However, 14 out of 19 subjects were classified as adherent (75%) and three as nonadherent (15%), in contrast to 19 (100%) that were claimed to be adherent based on the results of the qualitative urine screening. Nevertheless, further data is needed to estimate whether plasma quantification is superior in terms of assessing adherence to antihypertensive medication.

Simultaneous Measurement of Temperature and Refractive Index Using High Temperature Resistant Pure Quartz Grating Based on Femtosecond Laser and HF Etching.

The optical fiber temperature and refractive index sensor combined with the hollow needle structure for medical treatment can promote the standardization of traditional acupuncture techniques and improve the accuracy of body fluid analysis. A double-parameter sensor based on fiber Bragg grating (FBG) is developed in this paper. The sensor materials are selected through X-ray diffraction (XRD) analysis, and the sensor sensing principle is theoretically analyzed and simulated. Through femtosecond laser writing pure silica fiber, a high temperature resistant wavelength type FBG temperature sensor is obtained, and the FBG is corroded by hydrofluoric acid (HF) to realize a high-sensitivity intensity-type refractive index sensor. Because the light has dual characteristics of energy and wavelength, the sensor can realize simultaneous dual-parameter sensing. The light from the lead-in optical fiber is transmitted to the sensor and affected by temperature and refractive-index; then, the reflection peak is reflected back to the lead-out fiber by the FBG. The high temperature response and the refractive index response of the sensor were measured in the laboratory, and the high temperature characteristics of the sensor were verified in the accredited institute. It is demonstrated that the proposed sensor can achieve temperature sensing up to 1150 °C with the sensitivity of 0.0134 nm/°C, and refractive sensing over a refractive range of 1.333 to 1.4027 with the sensitivity of −49.044 dBm/RIU. The sensor features the advantages of two-parameter measurement, compact structure, and wide temperature range, and it exhibits great potential in acupuncture treatment.

Development and validation of viral load assays to quantitate SARS-CoV-2

SARS-CoV-2 has infected more than 30 million persons throughout the world. A subset of patients suffer serious consequences that require hospitalization and ventilator support. Current tests for SARS-CoV-2 generate qualitative results and are vital to make a diagnosis of the infection. However, they are not helpful to follow changes in viral loads after diagnosis. The ability to quantitatively assess viral levels is necessary to determine the effectiveness of therapy with anti-viral or immune agents. Viral load analysis is also necessary to determine the replicative potential of strains with different mutations, emergence of resistance to anti-viral agents and the stability of viral nucleic acid and degree of RT-PCR inhibition in different types of collection media. Quantitative viral load analysis in body fluids, plasma and tissue may be helpful to determine the effects of the infection in various organ systems. To address these needs, we developed two assays to quantitate SARS-CoV-2. The assays target either the S or E genes in the virus, produce comparable viral load results, are highly sensitive and specific and have a wide range of quantitation. We believe that these assays will be helpful to manage the clinical course of infected patients and may also help to better understand the biology of infection with SARS-CoV-2.

The Pediatric Fluid Cytology: A 2-year experience of a tertiary care pediatric center of North India

Background: Body fluid analysis containing exfoliated cells in effusion may reveal information about neoplastic and non-neoplastic etiology. Most important indication of fluid cytology is to look for malignant cells. CSF examination is another investigation performed routinely in all tertiary care centers in addition to other body fluids examined.&#x0D; Aims and Objective: The aim of the study was to examine the body fluids for cytological examination in diagnosis, prognostic and therapeutic tool for management of pediatric cases.&#x0D; Materials and Methods: Retrospective data analysis of 170 fluid cytology cases taken from departmental data archive of pediatric cases (0-18 years) from Jan 2018-Dec 2019 was tabulated observation was done by 2independent pathologists. The smears were stained with Romanowsky stains and specialized stains of AFB and Rhodamine auramine, MPO, PAS and PAP as per requirement.&#x0D; Results: There were higher number of male (n=99, 58.23%) compared to female (n=71, 41.76%). The commonest fluid cytology received was the CSF (n=150, 88.23%) with 77 samples presenting with significantly high TLC for age (using standard age analysis parameters). The diagnosis was grouped into the Neoplastic and Non neoplastic category. The non-neoplastic category was further divided into infective where most common was viral pleocytosis (n=50, 48 Viral lymphocytic pluecytosis, 1case rubella positive CSF, 1 Primary HLH with viral infection) followed by TB(n=10, 6 pleural, 2 CSF, 2 Peritoneal), bacterial (n=07, microbiology culture was done) and TORCH, Rubella with plasmacytosis (n=01). Another non-neoplastic category was of inherited disease where single case of Griscelli’s syndrome was diagnosed showing hemophagocytosis on CSF examination. Neoplastic Cytology was seen in 07 cases where all the cases were hematolymphoid malignancies.&#x0D; Conclusion: This study concludes that fluid cytology is a useful diagnosis, prognostic, therapeutic tool in diagnosis and management of pediatric cases.

Rapid and noninvasive diagnosis of oral and oropharyngeal cancer based on micro-Raman and FT-IR spectra of saliva

Fast, sensitive, and noninvasive techniques are needed for better health care management, particularly when traditional biopsies could be replaced with appropriate analyses of body fluids, such as saliva. Here is presented a proof-of-concept study, which aims to test a recently developed saliva samples preparation method, for oral and oropharyngeal cancer diagnosis, using micro-Raman and Fourier transform infrared (FT-IR) spectroscopic techniques. The detected biomarker bands and the cancer classification rates are compared and discussed. Saliva samples were collected from healthy donors and pathologically confirmed oral and oropharyngeal cancer patients. Principal components analysis (PCA) and principal components analysis-linear discriminant analysis (PCA-LDA) chemometric methods were applied to build discrimination models for the test and control groups. Based on the differences between salivary spectra of healthy and cancer patients, several biomarker bands were identified. Noteworthy, a significant vibrational biomarker band at 2064 cm−1, assigned to thiocyanate, was observed in both the FT-IR and Raman data-set. Other cancer characteristic Raman bands were 754 cm−1 (tryptophan), 530 and 927 cm−1 (lysozyme), 1001 cm−1 (phenylalanine), while the FT-IR biomarker band was located at 1075 cm−1 (phosphodiester bonds stretching in DNA, RNA). The oral and oropharyngeal cancer was classified with an accuracy of 90% based on the micro-Raman data and 82% based on the FT-IR data set, respectively. The study showed that oral and oropharyngeal cancer can be differentiated from control saliva samples based on their respective micro-Raman and FT-IR spectral signatures, due to the biomolecular modifications induced by the disease.

Deproteinizing agent, a fore step to better bonding: A literature review

Deproteinization can be defined as a process of removing the protein from a substance, usually as a stage in chemical purification. It is a necessary step in many procedures for the chemical analysis of body fluids. In dentistry, deproteinization can be used for elimination of the organic substances from the enamel surface before etching, as it increases the orthodontic bond strength by creating predominantly Type 1 and 2 etch patterns. Various authors have experimented the effect of enamel deproteinization with 5.25% sodium hypochlorite (NaOCl) prior to phosphoric acid etching and its effect on the etching pattern and shear bond strength of different adhesive systems. This article has reviewed and summarized the different studies regarding the effectiveness of NaOCl as a deproteinizing agent including its alternatives.

Cytologic analysis of body fluids with an emphasis on malignant effusions

Introduction: Fluid cytology, a relatively non invasive technique, throws light on both malignant and non malignant causes of effusions. It especially contributes in cancer research and staging of various tumors. Materials and Methods: This was a retrospective study done over a period of two years from January 2014 to December 2015 in the department of Pathology, Kamineni Academy of Medical Sciences and Research Centre, Hyderabad. The body fluids included in the study were pleural, peritoneal, pericardial and synovial fluids. All other fluids were excluded. The relevant clinical data was noted. Gross, cell count and cytomorphological examinations of fluid were done. Results: Out of 302 cases, pleural fluids, 148 (49.0%) cases, were most common, followed by peritoneal fluid, 125 (41.39%) cases and least common was pericardial fluid, 8 (2.64%) cases. The maximum numbers of cases was in 5th decade. The age range was 3 years to 84 years. Female preponderance was observed with M: F ratio of 1: 1.17. Lymphocyte rich exudates were most common in pleural effusion. In peritoneal and pericardial effusions, transudates were more and suppurative inflammation was predominant in synovial fluid analysis. Over all, malignant effusions constituted 18.54% of effusions. Metastatic adenocarcinoma was the commonest malignancy detected in all body cavity effusions. Conclusions: Fluid cytology is relatively painless, simple, cost effective, rapid technique that yields quick and reliable results. Some cases may present major interpretative challenges to the pathologist. Ancillary studies such as cell count, biochemical, microbiologic evaluation, cell block and immunohistochemistry (IHC) study help in accurate identification of diagnosis. Keywords: Body fluids, Malignant effusions, Transudates.

Minireview: Applications of NMR-based metabolomics for the detection and characterisation of toxoplasmosis in felids.

Toxoplasmosis is an infection caused by the intercellular protozoan parasite Toxoplasma gondii. The parasite has the three-stage life cycle: oocysts, tachyzoites, and bradyzoites. Felids are the only known hosts for the sexual reproduction of T. gondii and, therefore, play a crucial role in the transmission of toxoplasmosis. A single cat could spread the parasite to many hosts. Due to the intercellular nature of the parasite, T. gondii strongly depends on a host's metabolism in order to leverage carbon and nutrient sources. Therefore, the parasite could be detected in body fluids via observation and analysis of metabolic alterations. A range of analytical techniques such as nuclear magnetic resonance (NMR), mass spectrometry coupled with liquid chromatography, and Raman spectroscopy could be applied for the analysis of body fluids of infected animals. However, NMR consists of highly specific analytical techniques due to high reproducibility, availability of a variety of databases, and the ability to obtain the structures of unknown compounds. We present the current extent of NMR-based metabolomics on felid toxoplasmosis and suggest future considerations.

How to Predict Metastasis in Luminal Breast Cancer? Current Solutions and Future Prospects.

Breast cancer metastasis is the main cause of breast cancer mortality. Luminal breast cancer represents the majority of breast cancer cases and, despite relatively good prognosis, its heterogeneity creates problems with a proper stratification of patients and correct identification of the group with a high risk of metastatic relapse. Current prognostic tools are based on the analysis of the primary tumor and, despite their undisputed power of prediction, they might be insufficient to foresee the relapse in an accurate and precise manner, especially if the relapse occurs after a long period of dormancy, which is very common in luminal breast cancer. New approaches tend to rely on body fluid analyses, which have the advantage of being non-invasive and versatile and may be repeated and used for monitoring the disease in the long run. In this review we describe the current, newly-developed, and only-just-discovered methods which are or may become useful in the assessment of the probability of the relapse.

Building Entrustable Professional Activities In Residency Training: Peripheral Blood Smear And Body Fluid Analysis

Abstract Introduction/Objective Entrustable professional activities (EPAs) are defined as specialty-specific tasks representing a unit of professional practice that can be entrusted to unsupervised performance by a trainee following attainment of sufficient task-specific competence. EPAs and periodic competency assessments also provide a framework for evaluating relevant ACGME milestones. We describe our experience creating EPAs for peripheral blood smear (PBS) and body fluid (BF) analysis through which residents became qualified to act as laboratory testing personnel. Methods Training occurred during a 6 week “boot camp” for PGY2 and PGY4 residents in July-August 2018 and July-August 2019. Training for PBS included didactic lectures in automated hematology and RBC morphology (2 hr) and WBC and platelet morphology (2 hr); faculty-guided microscope reviews of RBC (2 hr) and WBC morphology (2 hr) using a training checklist; completion of RBC and WBC self-assessment quizzes; and a 40 question graded exam that covered cell identification, lab protocols, and case scenarios. Training for BF included didactic lectures (2 hr); faculty-guided microscope review of BF slides using a training checklist; completion of a BF self-assessment quiz; and a 40 question graded exam that covered cell identification, lab protocol, and case scenarios. Following successful completion of the graded exam residents were deemed competent to perform unsupervised review of cases initially flagged as abnormal by laboratory technologists; they were required to obtain attending review prior to release of results in defined situations. Formal competency assessments according to CLIA standards were done at 6 and 12 months after initial training. Impact on laboratory workflow and turnaround time was assessed before and after training. Conclusion We successfully created EPAs for PBS and BF analysis through which residents became qualified to act as laboratory testing personnel. There was no adverse impact on laboratory turnaroud time, and the number of PBS and BF cases requiring attending pathologist review decreased. Residents appreciated this tangible opportunity to gain graduated responsibility that prepared them for future practice. Periodic competency assessments provide an opportunity to evaluate relevant ACGME milestones. Our training and assessment program and EPAs can serve as a template for other residency programs.

Microbiomic Analysis on Low Abundant Respiratory Biomass Samples; Improved Recovery of Microbial DNA From Bronchoalveolar Lavage Fluid.

In recent years the study of the commensal microbiota is driving a remarkable paradigm shift in our understanding of human physiology. However, intrinsic technical difficulties associated with investigating the Microbiomics of some body niches are hampering the development of new knowledge. This is particularly the case when investigating the functional role played by the human microbiota in modulating the physiology of key organ systems. A major hurdle in investigating specific Microbiome communities is linked to low bacterial density and susceptibility to bias caused by environmental contamination. To prevent such inaccuracies due to background processing noise, harmonized tools for Microbiomic and bioinformatics practices have been recommended globally. The fact that the impact of this undesirable variability is negatively correlated with the DNA concentration in the sample highlights the necessity to improve existing DNA isolation protocols. In this report, we developed and tested a protocol to more efficiently recover bacterial DNA from low volumes of bronchoalveolar lavage fluid obtained from infants and adults. We have compared the efficiency of the described method with that of a commercially available kit for microbiome analysis in body fluids. We show that this new methodological approach performs better in terms of extraction efficiency. As opposed to commercial kits, the DNA extracts obtained with this new protocol were clearly distinguishable from the negative extraction controls in terms of 16S copy number and Microbiome community profiles. Altogether, we described a cost-efficient protocol that can facilitate microbiome research in low-biomass human niches.

Non-Invasive Biomarkers for Early Detection of Breast Cancer.

Simple SummaryEarly diagnosis of breast cancer greatly increases the chance of cure and survival from the disease. The mammogram is widely used for early detection of breast cancer, but its effectiveness and accuracy have been a concern for a long time as well as its inability in detecting small cancers, especially in women with dense breast tissues. Therefore, it is an unmet clinical need to develop a simple, convenient test to overcome the shortcomings of mammography. Liquid biopsy, which is based on the analysis of body fluids, has attracted much attention in the search for cancer biomarkers. Recent advances in analytical techniques have gradually made it possible to detect breast cancer early through a biomarker analysis of blood, nipple aspirate fluid, sweat, urine, tears, or the breath. We envision that a simple blood or breath test holds great promise as a biomarker for early detection of breast cancer in the near future.Breast cancer is the most common cancer in women worldwide. Accurate early diagnosis of breast cancer is critical in the management of the disease. Although mammogram screening has been widely used for breast cancer screening, high false-positive and false-negative rates and radiation from mammography have always been a concern. Over the last 20 years, the emergence of “omics” strategies has resulted in significant advances in the search for non-invasive biomarkers for breast cancer diagnosis at an early stage. Circulating carcinoma antigens, circulating tumor cells, circulating cell-free tumor nucleic acids (DNA or RNA), circulating microRNAs, and circulating extracellular vesicles in the peripheral blood, nipple aspirate fluid, sweat, urine, and tears, as well as volatile organic compounds in the breath, have emerged as potential non-invasive diagnostic biomarkers to supplement current clinical approaches to earlier detection of breast cancer. In this review, we summarize the current progress of research in these areas.

Genetics meets proteomics: perspectives for large population-based studies.

Proteomic analysis of cells, tissues and body fluids has generated valuable insights into the complex processes influencing human biology. Proteins represent intermediate phenotypes for disease and provide insight into how genetic and non-genetic risk factors are mechanistically linked to clinical outcomes. Associations between protein levels and DNA sequence variants that colocalize with risk alleles for common diseases can expose disease-associated pathways, revealing novel drug targets and translational biomarkers. However, genome-wide, population-scale analyses of proteomic data are only now emerging. Here, we review current findings from studies of the plasma proteome and discuss their potential for advancing biomedical translation through the interpretation of genome-wide association analyses. We highlight the challenges faced by currently available technologies and provide perspectives relevant to their future application in large-scale biobank studies.